Kunshan/China, August 5, 2021 – Sanner is set for further growth in the Asian markets. Following rapidly increasing customer demands in this region, the company is now planning to build a second production site in Kunshan. Once it takes up operation, a production output rise of around 80 percent is expected.

Following the rapid increase of customer orders in Asia, the current production site of Sanner Pharmaceutical & Medical Packaging Materials (Kunshan) Co., Ltd. (Sanner of China) is reaching the upper limits of its capacities. Hence, the company decided to build a second production site near to the existing one in Kunshan. The land transaction process is expected to be completed in August, and construction will start in September 2021. The new production site will be put into operation before the end of next year

New clean room production and additional development capacities

The new site will feature additional 3,000 square meters (approx. 32,300 square feet) of clean room production facilities. Moreover, the site will be equipped with a GMP warehouse, a mold assembly and maintenance workshop, all kinds of auxiliary equipment, as well as an office area. “Our new Kunshan site will meet the most demanding customer requirements thanks to advanced production equipment with a high degree of automation. This will secure our existing hightech status for the future,” says Ralf Tiemann, CEO Asia Pacific at Sanner

The new site will feature additional 3,000 square meters (approx. 32,300 square feet) of clean room production facilities. Moreover, the site will be equipped with a GMP warehouse, a mold assembly and maintenance workshop, all kinds of auxiliary equipment, as well as an office area. “Our new Kunshan site will meet the most demanding customer requirements thanks to advanced production equipment with a high degree of automation. This will secure our existing hightech status for the future,” says Ralf Tiemann, CEO Asia Pacific at Sanner.

Apart from more production space for the existing portfolio, the site will also provide additional capacities for research, development, and production of Sanner’s new products, such as customized pharmaceutical primary packaging or intelligent medtech solutions. “2020 was again a highly successful year for Sanner. With around 35 million Euros of annual sales, Sanner of China contributed significantly to the record sales result of the entire Sanner group,” Tiemann underlines. “We will achieve the next milestone with the inauguration of our new production site. With the new facility, we will have the ability to increase production output by 80 percent.”

Ralf Tiemann, CEO Asia Pacific at Sanner: „After a highly successful year 2020, we will achieve the next milestone in China with the inauguration of our new production site.“
Sanner of China’s new plant will provide a clean room area, significantly increased production space, as well as additional capacities for research and development.

About Sanner

Based in Bensheim, Germany, Sanner GmbH was founded in 1894 and is now in its fourth generation as a family-owned enterprise. Sanner develops and produces highquality plastic packaging and components for pharmaceutical, medtech, diagnostics and healthcare products. The world’s leading manufacturer of desiccant closures and effervescent packaging solutions, Sanner produces four billion plastic parts each year for standard and customized packaging solutions. With almost 600 employees in Germany, China, France, Hungary, the U.S., India and Indonesia, the company generated annual sales of approx. 98 million euros in 2020. For further information: www.sannergroup.com.

Media contact

Commha Consulting GmbH & Co. KG

Annette Crowther

Poststraße 48

69115 Heidelberg

Germany

Tel. +49 (0)6221 18779-27

sanner@commhaconsulting.com

You may also like